Review Papers Claim by Claim

 Quick Explanation Copied

 Long Explanation

Sarcomeric Evidence in Fast-Twitch Quadriceps Fibres

Manders and colleagues biopsied vastus lateralis from 11 female idiopathic PAH patients and 8 age/sex-matched controls, then skinned individual fibres to isolate sarcomere function from upstream excitation–contraction coupling (https://doi.org/10.1183/09031936.00205114). Fast-twitch fibres from PAH patients generated less maximal tension (192±5 vs 226±8 mN·mm⁻²; p<0.005) without fibre CSA differences (3387±280 vs 3307±242 µm²; p=0.84), so the deficit is qualitative, not atrophic. The elegant logic chain: unchanged force-redevelopment rate (ktr) rules out altered strongly-bound cross-bridge fraction; reduced active stiffness with unchanged tension/stiffness ratio localizes the defect to fewer available cross-bridges—likely myosin loss (https://doi.org/10.1183/09031936.00205114). Ca²⁺ sensitivity (EC50) was also unaltered.

Unexpected Titin Finding and Therapeutic Speculation

Passive tension paradoxically rose (+39% at 2.5 µm sarcomere length), opposite to what disuse/myosin loss predicts (https://doi.org/10.1183/09031936.00205114). The authors' compensatory-titin hypothesis (lattice-spacing preservation of Ca²⁺ sensitivity) is frankly labelled speculative and remains untested. The suggestion of calcium sensitisers as therapy is a hypothesis, not established evidence for PAH skeletal muscle. The ~15% single-fibre deficit vs 20–30% in vivo weakness implies extrassarcomeric contributions (excitation–contraction coupling, atrophy) the authors acknowledge (https://doi.org/10.1183/09031936.00205114).

Critical Appraisal

Findings apply only to fast-twitch fibres (PAH: 4 patients/5 fibres of slow fibre data excluded; human vastus lateralis is 30–40% slow-twitch), limiting extrapolation. Experiments were not blinded—the physiologist also obtained biopsies—a stated limitation. Mechanistically, reduced cross-bridge number without myosin protein quantification is inference; direct myosin content assays would strengthen the causal claim. Fibre type shift toward fast-fatigable fibres in PAH (reported inconsistently in prior work cited within) could partly explain the apparent deficit if PAH biopsies contained a different fast-fibre subtype distribution. Confidence: moderate—solid physiological technique, but small, single-centre, female-only cohort with acknowledged unblinding.

 BGPT Paper Review

Study Novelty

First direct single-fibre demonstration of sarcomeric dysfunction in PAH quadriceps; prior work showed diaphragm effects and whole-muscle weakness, but peripheral sarcomere-level mechanisms were unknown.

Scientific Quality

Rigorous permeabilised-fibre methodology with logical mechanistic decomposition, but unblinded experiments, small female-only cohort, exclusion of slow-twitch data, and absence of direct myosin quantification reduce confidence.

Study Generality

Findings apply to fast-twitch vastus lateralis fibres of idiopathic PAH; extrapolation to whole muscle, other PAH subtypes, males, and slow fibres is uncertain by the authors' own admission.

Study Usefulness

Mechanistically reframes PAH peripheral weakness as partly sarcomeric and motivates cross-bridge/myosin-targeted and calcium-sensitiser research directions beyond right-heart-centric explanations.

Study Reproducibility

Permeabilised-fibre methods are well established and reported, but no data/code sharing, unblinded measurements, and biopsy-timing details hinder exact replication.

Explanatory Depth

Decomposes force into cross-bridge fraction, number, and force per bridge with matching measurements; the passive-tension paradox and myosin-loss hypothesis remain under-specified.